Global Antibiotic R&D Partnership (GARDP)

The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential...

Antibiotic resistance,antibiotic drug development,r&d partnerships,serious bacterial infections,children’s antibiotics,sexually transmitted infections,global health,public health,pandemic preparedness,antibiotic access,sepsis and neonatal sepsis,and gonorrhoea

Global antibiotic r&d partnership (gardp) operates in the Research services industry.

Global antibiotic r&d partnership (gardp)'s revenue is 11m - 100m

Global antibiotic r&d partnership (gardp) has 51 - 200 employees.